ロード中...
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab
Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed and we performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefit in terms of pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS...
保存先:
| 出版年: | Pharmacogenet Genomics |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5965682/ https://ncbi.nlm.nih.gov/pubmed/29768301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000337 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|